San Francisco startup Structure Therapeutics is also working on an oral, as soon as-day-to-day GLP-one drug referred to as GSBR-1290—the drug surpassed Wall Avenue’s expectations in June whenever a mid-phase analyze confirmed normal weight loss of close to 6% and it options to start out A different mid-stage demo toward the tip of the yr—that… Read More